Peptide T blocks GP120/CCR5 chemokine receptor-mediated chemotaxis

Clinical Immunology

Volumn 93, Issue 2, 1999, Pages 124-131

  Redwine, Laura S ^a   Pert, Candace B ^a   Rone, Janice D ^a   Nixon, Robin ^a   Vance, Matthew ^a   Sandler, Bryan ^a   Lumpkin, Michael D ^a   Dieter, Douglas J ^a   Ruff, Michael R ^a  

^a GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

CCR5; Chemokine; Chemotaxis; GP120; HIV; Peptide T

Indexed keywords

CHEMOKINE RECEPTOR CCR5; CHEMOTAXIS INHIBITOR; GLYCOPROTEIN GP 120; PEPTIDE T; RANTES;

ARTICLE; CHEMOTAXIS; CONTROLLED STUDY; DRUG EFFECT; DRUG SCREENING; HUMAN; HUMAN CELL; MONOCYTE; PRIORITY JOURNAL; RECEPTOR BINDING; SIGNAL TRANSDUCTION;

EID: 0032719756     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1006/clim.1999.4771     Document Type: Article

References (43)

1. Pert, C. B., Hill, J. M., Ruff, M. R., Berman, R. M., Robey, W. G., Arthur, L. O., Ruscetti, F. W., and Farrar, W. L., Octapeptides deduced from the neuropeptide receptor-like pattern of antigen T4 in brain potently inhibit human immunodeficiency virus receptor binding and T-cell infectivity. Proc. Natl. Acad. Sci. USA 83, 9254-9258, 1986.
2. Ruff, M. R., Martin, B. M., Ginns, E. I., Farrar, W. L., and Pert, C. B., CD4 receptor binding peptides that block HIV infectivity cause human monocyte chemotaxis. Relationship to vasoactive intestinal polypeptide. FEBS Lett. 211, 17-22, 1987.
3. Kornfeld, H., Cruikshank, W. W., Pyle, S. W., Berman, J. S., and Center, D. M., Lymphocyte activation by HIV-1 envelope glycoprotein. Nature 335, 445-448, 1988.
4. Davis, C. B., Dikic, I., Unutmaz, D., Hill, C. M., Arthos, J., Siani, M. A., Thompson, D. A., Schlessinger, J., and Littman, D. R., Signal transduction due to HIV-1 envelope interactions with chemokine receptors CXCR4 or CCR5. J. Exp. Med. 186, 1793-1798, 1997.
5. Lapham, C. K., Ouyang, J., Chandrasekhar, B., Nguyen, N. Y., Dimitrov, D. S., and Golding, H., Evidence for cell-surface association between fusin and the CD4-gp120 complex in human cell lines. Science 274, 602-65, 1996.
6. Trkola, A., Dragic, T., Arthos, J., Binley, J. M., Olson, W. C., Allaway, G. P., Cheng-Mayer, C., Robinson, J., Maddon, P. J., and Moore, J. P., CD-4 dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR5. Nature 384, 184-187, 14 November 1996.
7. + T cells. Science 270, 1811, 1995.
8. Brenneman, D. E., Westbrook, G. L., Fitzgerald, S. P., Ennist, D. L., Elkins, K. L., Ruff, M. R., and Pert, C. B., Neuronal cell killing by the envelope protein of HIV and its prevention by vasoactive intestinal peptide. Nature 335, 639-642, 1988.
9. Zorn, N. E., Weill, C. L., and Russell, D. H., The HIV protein, GP120, activates nuclear protein kinase C in nuclei from lymphocytes and brain. Biochem. Biophys. Res. Commun. 166, 1133-1139, 1990.
10. Liapi, C., Takahashi, N., Raynaud, F., Evain-Brion, D., and Anderson, W. B., Effects of [D-Ala1] peptide T-NH2 and HIV envelope glycoprotein gp120 on cyclic AMP dependent protein kinases in normal and psoriatic human fibroblasts. J. Invest. Dermatol. 110, 332-337, 1998.
11. Mulroney, S. E., McDonnell, K., Pert, C. B., Ruff, M. R., Samson, W. K., and Lumpkin, M. D., HIV GP120 inhibits the somatotropic axis: A possible GHRH receptor mechanism for the pathogenesis of AIDS wasting. Proc. Natl. Acad. Sci. USA 1998.
12. Heseltine, P. N., Goodkin, K., Atkinson, J. H., Vitiello, B., Rochon, J., Heaton, R. K., Eaton, E. M., Wilkie, F. L., Sobel, E., Brown, S. J., Feaster, D., D., Schneider, L., Goldschmidts, W. L., and Stover, E. S., Randomized double-blind placebo-controlled trial of peptide T for HIV-associated cognitive impairment. Arch. Neurol. 55, 41-51, 1998.
13. Kosten, T. R., Rosen, M. I., McMahon, T. L., Bridge, T. P., O'Malley, S. S., Pearsall, R., and O'Connor, P. G., Treatment of early AIDS dementia in intravenous drug users: High versus low dose peptide T. Am. J. Drug Alcohol Abuse 23, 543-553, 1997.
14. Wetterberg, L., Alexius, B., Saaf, J., Sonnerborg, A., Britton, S., and Pert, C., Peptide T in treatment of AIDS [letter]. Lancet 1, 159, 1987.
15. Villemagne, V. L., Phillips, R. L., Liu, X., Gilson, S. F., Dannals, R. F., Wong, D. F., Harris, P. J., Ruff, M., Pert, C., Bridge, P., and London, E. D., Peptide T and glucose metabolism in AIDS dementia complex. J. Nucl. Med. 37, 1177-1180, 1996.
16. Ruff, M. R., Hallberg, P. L., Hill, J. M., and Pert, C. B., Peptide T[4-8] is core HIV envelope sequence required for CD4 receptor attachment. Lancet 2, 751, 1987. [letter]
17. Koito, A., Stamatatos, L., and Cheng-Mayer, C., Small amino acid sequence changes within the V2 domain can affect the function of a T-cell line-tropic human immunodeficiency virus type 1 envelope gp120. Virology 206, 878-84, 1995.
18. Toohey, K., Wehrly, K., Nishio, J., Perryman, S., and Chesebro, B., Human immunodeficiency virus envelope V1 and V2 regions influence replication efficiency in macrophages by affecting virus spread. Virology 213, 70-9, 1995.
19. Kwong, P. D., Wyatt, R., Robinson, J., Sweet, R. W., Sodroski, J., and Hendrickson, W. A., Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody. Nature 393, 648-659, 1998.
20. Spisani, S., Gavioli, R., Giuliani, A. L., Cavalletti, T., Marastoni, M., Balboni, G., Salvadori, S., Tomatis, R., and Traniello, S., Chemotactic response of human monocytes to pentapeptide analog derived from immunodeficiency virus protein gp 120. Inflammation 14, 55-60, 1990.
21. Marastoni, M., Salvadori, S., Balboni, G., Spisani, S., Gavioli, R., Traniello, S., and Tomatis, R., Synthesis, metabolic stability and chemotactic activity of peptide T and its analogues. Int. J. Pept. Protein Res. 35, 81-88, 1990.
22. Marastoni, M., Salvadori, S., Balboni, G., Spisani, S., Gavioli, R., Traniello, S., and Tomatis, R., Chemotactic response of human monocytes to pentapeptide analogs derived from immunodeficiency virus protein gp120. Inflammation 14, 55-60, 1990.
23. Brenneman, D., E., Buzy, J. M., Ruff, M. R., and Pert, C. B., Peptide T sequences prevent neuronal cell death produced by the envelope protein (gp120) of the human immunodeficiency virus. Drug Dev. Res. 15, 361-369, 1988.
24. Raport, C. J., Gosling, J., Schweichart, V. L., Gray, P., and Charos, I. F., Molecular cloning and functional characterization of a novel human CC chemokine receptor (CCR5) for RANTES, MIP-1b, and MIP-1a. J. Biol. Chem. 271, 17161-17166, 1996.
25. Wang, J., Roderiquez, G., Oravecz, T., and Norcross, M., Cytokine regulation of human immunodeficiency virus type-1 entry and replication in human monocytes/macrophages through modulation of CCR5 expression. J. Immunol. 1998.
26. Bleul, C., Farzan, M., Choe, H., Parolin, C., Clark-Lewis, I., Sodroski, J., and Springer, T. A., The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature 382, 829-33, 1996.
27. Madani, N., Kozak, S. L., Kavanaugh, M. P., and Kabat, D., gp120 envelope glycoproteins of human immunodeficiency viruses competitively antagonize signaling by coreceptors CXCR4 and CCR5. Proc. Natl. Acad. Sci. USA 95, 8005-8010, 1998.
28. Motta, A., Picone, D., Temussi, P. A., Marastoni, M., and Tomatis, R., Conformational analysis of peptide T and of its C-pentapeptide fragment. Biopolymers 28, 479-486, 1989.
29. Raychaudhuri, S. K., Raychaudhuri, S. P., and Farber, E. M., Anti-chemotactic activities of peptide T: A possible mechanism for its therapeutic effects in psoriasis. Int. J. Immunopharmacol. 19, [in press]
30. Huang, Y., Paxton, W. A., Wolinsky, S. M., Neumann, A. U., Zhang, L., He, T., Kang, S., Ceradini, D., Jin, Z., Yazdanbakhsh, K., Kunstman, K., Erickson, D., Dragon, E., Landau, N. R., Phair, J., Ho, D. D., and Koup, R. A., The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. Nature Med. 2, 1240-123, 1996.
31. Weissman, D., Rabin, R. L., Arthos, J., Rubbert, A., Dybul, M., Swofford, R., Venkatesan, S., Farber, J. M., and Fauci, A. S., Macrophage-tropic HIV and SIV envelope proteins induce a signal through the CCR5 chemokine receptor. Nature 389, 981-985, 1997.
32. Wahl, S. M., Allen, J. B., Gartner, S., Orenstein, J. M., Popovic, M., Chenoweth, D. E., Arthur, L. O., Farrar, W. L., and Wahl, L. M., HIV-1 and its envelope glycoprotein down-regulate chemotactic ligand receptors and chemotactic function of peripheral blood monocytes. J. Immunol. 142, 3553-3559, 1989.
33. Wang, J. M., Ueda, H., Howard, O. M., Grimm, M. C., Chertov, O., Gong, X., Gong, W., Resau, J. H., Broder, C. C., Evans, G., Arthur, L. O., Ruscetti, F. W., and Oppenheim, J. J., HIV-1 envelope gp120 inhibits the monocyte response to chemokines through CD4 signal-dependent chemokine receptor down-regulation. J. Immunol. 161, 4309-4317, 1998.
34. Dreyer, E. B., Kaiser, P. K., Offermann, J. T., and Lipton, S. A., HIV-1 coat protein neurotoxicity prevented by calcium channel antagonists. Science 248, 364-367, 1990.
35. Nomizu, M., Kim, W. H., Yamamura, K., Utani, A., Song, S. Y., Otaka, A., Roller, P. P., Kleinman, H. K., and Yamada, Y., Identification of cell binding sites in the laminin alpha 1 chain carboxyl-terminal globular domain by systematic screening of synthetic peptides. J. Biol. Chem. 270, 20583-20590, 1995.
36. Rizzuto, C. D., Wyatt, R., Hernandez-Ramos, N., Sun, Y., Kwong, P. D., Hendrickson, W. A., and Sodroski, J., A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding. Science 280, 1949-1953, 1998.
37. Ivanoff, L. A., Dubay, J. W., Morris, J. F., Roberts, S. J., Gutshall, L., Sternberg, E. J., Hunter, E., Matthews, T. J., and Petteway, S. R. J., V3 loop region of the HIV-1 gp120 envelope protein is essential for virus infectivity. Virology 187, 423-432, 1992.
38. Lasky, L. A., Nakamura, G., Smith, D. H., Fennie, C., Shimasaki, C., Patzer, E., Berman, P., Gregory, T., and Capon, D. J., Delineation of a region of the human immunodeficiency virus type 1 gp120 glycoprotein critical for interaction with the CD4 receptor. Cell 50, 975-985, 1987.
39. - binding region of human immunodeficiency virus type 1 gp120 envelope glycoprotein. J. Virol. 66, 5635-5641, 1992.
40. Mondor, I., Moulard, M., Ugolini, S., Klasse, P. J., Hoxie, J., Amara, A., Delaunay, T., Wyatt, R., Sodroski, J., and Sattentau, Q. J., Interactions among HIV gp120, CD4, and CXCR4: Dependence on CD4 expression level, gp120 viral origin, conservation of the gp120 COOH- and NH2-termini and V1/V2 and V3 loops, and sensitivity to neutralizing antibodies. Virology 248, 394-405, 1998.
41. Landau, N. R., and Littman, D. R., Packaging system for rapid production of murine leukemia virus vectors with variable tropism. J. Virol. 66, 5110-5113, 1992.
42. Owman, C., Garzino-Demo, A., Cocchi, F., Popovic, M., Sabirsh, A., and Gallo, R. C., The leukotriene B4 receptor functions as a novel type of coreceptor mediating entry of primary HIV-1 isolates into CD4-positive cells. Proc. Natl. Acad. Sci. USA 95, 9530-9534, 1998.
43. Ali, H., Richardson, R. M., Haribabu, B., and Snyderman, R., Chemoattractant receptor cross-desensitization. J. Biol. Chem. 274, 6027, 1999.